PROGRESSIVE CORP/OH/ (PGR)
The Company disclosed financial results for the month and year-to-date periods ended May 31, 2026, via a news release furnished under Regulation FD.
View raw filing on EDGAR →Filings Radar
SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
PUBLIX SUPER MARKETS INC
The Board elected Jill Livesay as a non-employee director effective July 1, 2026, and appointed her to the Audit Committee, expanding the Board from eight to nine members.
View raw filing on EDGAR →BRINKER INTERNATIONAL, INC (EAT)
Brinker International issued a notice of redemption for all outstanding 8.250% Senior Notes due July 15, 2030, with redemption scheduled for July 15, 2026 at 104.125% of principal plus accrued interest. This is a material debt management event affecting the company's capital structure and liquidity, but does not fit neatly into the more specific taxonomy categories (not a covenant breach, not a restatement, not M&A activity). The redemption of a substantial debt obligation is material to investors assessing the registrant's financial position and cash flow.
View raw filing on EDGAR →IPALCO ENTERPRISES, INC.
The IURC issued a Rate Order on June 17, 2026 approving a Stipulation and Settlement Agreement for AES Indiana's base rate case, establishing a $1,979.7 million revenue requirement, 9.5% return on common equity, and $5.5 billion rate base effective in two phases beginning July 2026. This is a material regulatory approval affecting the subsidiary's revenue and profitability, but does not fit neatly into the specific event categories (not earnings, M&A, impairment, litigation, or other defined types). The disclosure is material to investors as it directly impacts the registrant's financial performance and regulatory standing.
View raw filing on EDGAR →BEST BUY CO INC (BBY)
This is a clear disclosure of shareholder vote results from Best Buy's June 12, 2026 Annual Meeting of Shareholders under Item 5.07. The filing reports voting outcomes on five matters: election of 13 directors, ratification of Deloitte & Touche LLP as independent auditor, advisory vote on executive compensation, and two shareholder proposals. All directors were elected with substantial majorities, the auditor was ratified, and executive compensation was approved, making this a material governance event that affects investor understanding of the company's board composition and shareholder sentiment.
View raw filing on EDGAR →ALASKA AIR GROUP, INC. (ALK)
Shane Tackett was elected as president of Alaska Airlines effective June 29, 2026. The appointment also included compensatory arrangements including a salary increase to $692,804, increased cash incentive target to 105% of base salary, and a $3,000,000 long-term incentive award target.
View raw filing on EDGAR →Sleep Number Corp (SNBR)
Sleep Number received written notice from Nasdaq on June 16, 2026, that its common stock will be delisted from Nasdaq effective June 23, 2026, pursuant to Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1. The delisting was triggered by the Company's Chapter 11 bankruptcy filing on June 12, 2026, and associated concerns about residual equity interest and ability to sustain listing compliance. This is a definitive delisting notice, not merely a risk or warning, making it a material event that fundamentally affects the trading and liquidity of the Company's securities.
View raw filing on EDGAR →Creative Media & Community Trust Corp (CMCT)
The filing discloses unregistered issuances of Common Stock on three dates (May 12, May 28, and June 15, 2026) totaling approximately 308,679 shares in exchange for redemptions of Series A1 and Series A Preferred Stock. The conversion prices declined sharply from $6.36 to $5.41 to $4.30 per share over the period, indicating deteriorating valuation. These are classic dilutive equity issuances that would materially affect shareholder ownership and are properly classified under Item 3.02.
View raw filing on EDGAR →Aspira Women's Health Inc. (AWHL)
This is a clear disclosure of shareholder vote results from the June 17, 2026 annual meeting of stockholders, covering four proposals: election of six directors, advisory vote on named executive officer compensation, approval of an amendment to the 2019 Stock Incentive Plan, and ratification of the independent auditor (BDO USA, P.C.). The filing presents detailed voting tallies for each proposal, which is the hallmark of Item 5.07 disclosure and the shareholder_vote_results event type.
View raw filing on EDGAR →Alvotech (ALVOW)
Alvotech announced and priced a $152 million underwritten public offering of 22.67 million ordinary shares at $3.75 per share, concurrent with a private placement of 17.83 million shares to European investors at the same price. The combined offering raises approximately $152 million in gross proceeds and significantly increases share count, with proceeds intended for development, working capital, and potential debt repayment.
View raw filing on EDGAR →5C Lending Partners Corp.
This Item 5.07 filing discloses the results of the Annual Meeting of Stockholders held on June 16, 2026, including voting outcomes for three proposals: election of two Class II directors (Robert Gheewalla and Michael Koester), ratification of Deloitte & Touche LLP as independent auditor, and approval of a charter amendment regarding liquidation voting thresholds. The filing presents certified vote tabulations for each proposal, which is the core disclosure required under Item 5.07.
View raw filing on EDGAR →KFORCE INC (KFRC)
Kforce entered into a Rule 10b5-1 stock trading plan on June 15, 2026 to repurchase its own common stock under a Board-authorized share repurchase program. While share buybacks are generally material corporate actions affecting capital allocation and shareholder value, this disclosure does not fit neatly into the more specific event categories (it is not a dilutive issuance, M&A activity, or executive compensation). The filing is material because it signals the Firm's intent to return capital and reflects management's confidence in the stock, but the event type is best classified as "other_material" given the absence of a dedicated taxonomy entry for routine buyback plan adoptions.
View raw filing on EDGAR →QXO, Inc. (QXO-PB)
QXO completed a $3.0 billion debt offering on June 17, 2026, explicitly designated as financing for the previously announced proposed acquisition of TopBuild Corp. The proceeds are held in escrow pending consummation of the acquisition, with a mandatory redemption trigger if the acquisition is not completed by January 31, 2027.
View raw filing on EDGAR →Simulations Plus, Inc. (SLP)
Simulations Plus entered into an Agreement and Plan of Merger whereby the company will be acquired by SP Evolution HoldCo II, LLC (an Altaris affiliate) for $18.50 per share in an all-cash transaction. The merger agreement details consideration, closing conditions, financing commitments, and termination provisions.
View raw filing on EDGAR →W. P. Carey Inc. (WPC)
A material tenant insolvency affecting 16 properties and $15.2 million in annualized rent, with estimated rent loss of $8–12 million impacting full-year AFFO guidance. While the event does not fit cleanly into traditional litigation categories, it represents a material adverse event to the registrant's cash flows and financial condition.
View raw filing on EDGAR →RIGEL PHARMACEUTICALS INC (RIGL)
The filing discloses completion of a License Agreement with Arvinas and Pfizer granting Rigel exclusive global rights to develop, manufacture, and commercialize VEPPANU™ (vepdegestrant). The transaction involved a $70.0 million upfront payment and required HSR clearance, constituting a material acquisition of asset rights that would affect investor assessment of the company's product pipeline and financial position.
View raw filing on EDGAR →Elemental Royalty Corp (ELE)
Elemental announces inclusion in three major stock indexes: Russell 3000®, Russell 2000®, and S&P/TSX Global Gold Index, effective June 22–26, 2026. Index inclusion is a material operational/strategic milestone that increases visibility to institutional investors and typically drives positive market recognition, though it is not a discrete financial event (earnings, M&A, debt issuance) or governance action. The announcement emphasizes this as "another important milestone in the Company's continued growth" and notes the $12.2 trillion in assets benchmarked to Russell indexes, indicating material investor-facing significance.
View raw filing on EDGAR →Largo Inc. (LGO)
This press release announces the voting results from Largo's Annual General and Special Meeting of Shareholders held on June 16, 2026. The disclosure reports that shareholders voted to approve all matters, including election of all five director nominees, appointment of KPMG LLP as auditors, and approval of the amended and restated share compensation plan, with detailed voting tallies for each director. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and is material as it confirms governance decisions affecting the board composition and auditor appointment.
View raw filing on EDGAR →Largo Inc. (LGO)
This exhibit is a formal report of voting results from Largo Inc.'s annual general and special meeting of shareholders held on June 16, 2026, disclosing outcomes on four matters: fixing the number of directors (approved 98.7%), election of five directors (all approved with 83–99% support), re-appointment of KPMG LLP as auditors (approved 99.7%), and approval of the Amended and Restated Share Compensation Plan (approved 84.1%). The document explicitly states it is filed "in accordance with section 11.3 of National Instrument 51-102 - Continuous Disclosure Obligations," confirming it is a shareholder vote-results disclosure required by Canadian securities law.
View raw filing on EDGAR →LESAKA TECHNOLOGIES INC (LSAK)
Lesaka's subsidiary entered into a Transaction Implementation Agreement with Zero Research, Bank Zero, and multiple shareholders, indicating a material acquisition or merger transaction. The disclosure explicitly references Item 1.01 (Entry Into a Material Definitive Agreement), conditions precedent, and an extended closing deadline (January 31, 2027), all hallmarks of M&A activity. This would materially affect investor assessment of the registrant's strategic direction and financial position.
View raw filing on EDGAR →IAMGOLD CORP (IAG)
IAMGOLD announced an amendment to its senior secured revolving credit facility, increasing total commitments from $650 million to $850 million and extending maturity to June 17, 2030. While the facility remains undrawn, this represents a material modification of the Company's direct financial obligations and credit structure, with improved pricing (SOFR plus 1.875%–2.875% vs. prior 2.75%–3.75%) and enhanced covenant flexibility. This is a creation/amendment of a credit facility, which falls under debt_issuance per the taxonomy.
View raw filing on EDGAR →NEOGENOMICS INC (NEO)
NeoGenomics disclosed the pricing of a convertible senior notes offering to qualified institutional buyers under Rule 144A. Convertible notes are inherently dilutive securities that can be converted into equity, making this a material capital-raising event that would affect investor assessment of share dilution and the company's financing strategy.
View raw filing on EDGAR →Ascent Solar Technologies, Inc. (ASTI)
Ascent Solar held its 2026 Annual Meeting of Stockholders on June 17, 2026, with stockholders voting on five proposals: election of two Class A directors (Louis Berezovsky and Forrest Reynolds), ratification of Haynie & Company as independent auditor, approval of an amendment to the 2023 Equity Incentive Plan increasing the share reserve from 893,611 to 1,700,000 shares, advisory approval of named executive officer compensation, and approval to adjourn the meeting. All proposals were approved or elected as indicated.
View raw filing on EDGAR →DUOS TECHNOLOGIES GROUP, INC. (DUOT)
DUOS Technologies entered into an underwritten registered direct offering of 2,000,000 shares of common stock and 3,800,000 pre-funded warrants (exercisable at $0.001) for approximately $55 million in gross proceeds. The combination of a substantial equity issuance and highly dilutive pre-funded warrants represents a material capital raise that will significantly dilute existing shareholders.
View raw filing on EDGAR →ProtoKinetix, Inc. (PKTX)
ProtoKinetix appointed three individuals as directors on June 17, 2026, with Keith Brunt also appointed as president of the Company. Brunt's elevation to president represents a material executive role change, with extensive biographical detail provided on his qualifications.
View raw filing on EDGAR →ProtoKinetix, Inc. (PKTX)
ProtoKinetix formed a subsidiary (SightPath Biotech LLC) to develop PKX-001 for dry-eye disease with patents valued at approximately $253 million, disclosed late filings of its 2025 10-K and 2026 Q1 10-Q, and repriced 61.19 million options and 6 million warrants downward from $0.028 to $0.01 per share with extended expiration dates. The combination of subsidiary formation with substantial IP valuation, filing delays, and significant dilutive equity repricing reflects material corporate restructuring and financial stress.
View raw filing on EDGAR →ZIFF DAVIS, INC. (ZD)
Ziff Davis completed the sale of its Connectivity division to Accenture Inc. for $1.2 billion in cash on June 17, 2026, following entry into the Securities Purchase Agreement on March 2, 2026 and lender consent on June 15, 2026.
View raw filing on EDGAR →LFTD PARTNERS INC. (LIFD)
Richard Morrissy resigned from the Company's Board of Directors effective immediately on June 14, 2026, due to health concerns limiting his ability to serve. This is a clear director departure disclosure under Item 5.02, and board composition changes are material to investors assessing governance and continuity.
View raw filing on EDGAR →FAIRFAX FINANCIAL HOLDINGS LTD/ CAN (FRFFF)
Fairfax announces the launch of a C$300 million offering of 4.40% Senior Notes due 2036, to be priced at C$98.991 per C$100 principal amount. This is a material creation of a new direct financial obligation through debt issuance, with expected closing on June 19, 2026. The company intends to use proceeds for general corporate purposes including refinancing, debt repayment, or acquisition opportunities.
View raw filing on EDGAR →ELDORADO GOLD CORP /FI (EGO)
The exhibit is a news release announcing Eldorado's 2026 annual shareholder meeting and providing an update on board leadership transition. The material disclosure is the announcement that the Board is "advancing its leadership succession process to identify a successor to Steven Reid as Chair," with appointment expected by September 30, 2026. This is a governance event involving a change in board leadership (the Chair position), which is material to investors assessing the company's governance structure and continuity. While the exhibit also contains routine meeting logistics, the substantive disclosure is the Chair succession announcement.
View raw filing on EDGAR →X Financial (XYF)
The announcement discloses two executive changes: the resignation of Mr. Yufan Jiang as Chief Risk Officer effective July 1, 2026, and the appointment of Mr. Kan Li as Acting Chief Risk Officer effective the same date. While both a departure and appointment occur, the principal disclosed action is the appointment of Mr. Kan Li to the Chief Risk Officer role, a material C-suite position. The appointment of a new CRO at a fintech platform is material to investors assessing governance and risk management oversight.
View raw filing on EDGAR →AerSale Corp (ASLE)
This Item 5.07 disclosure presents the complete voting results from AerSale's Annual Meeting of Stockholders held June 11, 2026, including election of seven directors, advisory vote on executive compensation, redomestication from Delaware to Texas, and auditor ratification. All four proposals passed, with detailed vote tallies for each item. This is a standard shareholder vote results disclosure that is material to investors as it confirms board composition and key corporate governance matters.
View raw filing on EDGAR →Waterdrop Inc. (WDH)
This is a press release announcing Waterdrop Inc.'s unaudited financial results for the first quarter of 2026 (three months ended March 31, 2026). The document discloses net operating revenue of RMB1,242.2 million (up 64.8% YoY), operating profit of RMB80.0 million, and net profit attributable to ordinary shareholders of RMB98.4 million, along with detailed segment results, balance sheet, and cash flow information. This is a discrete earnings announcement, not a periodic financial report filing itself, and constitutes a material event affecting investor assessment of the registrant's financial performance.
View raw filing on EDGAR →Stellus Capital Investment Corp (SCM)
This is a clear disclosure of shareholder vote results from Stellus Capital's Annual Meeting of Stockholders held on June 16, 2026. The filing reports the voting outcomes for two proposals: (1) election of director Bruce R. Bilger with 13,650,012 votes for and 2,122,882 withheld, and (2) approval of a new investment advisory agreement with Stellus Capital Management, LLC with 14,244,374 votes for, 721,794 against, and 806,722 abstentions. This is a textbook Item 5.07 disclosure of shareholder meeting results.
View raw filing on EDGAR →Stellus Private Credit BDC
This is a clear disclosure of shareholder vote results from a Special Meeting held on June 16, 2026. The filing reports that shareholders voted to approve a new investment advisory agreement between Stellus Private Credit BDC and Stellus Private BDC Advisor, LLC, with 10,314,546 votes in favor and zero votes against or abstaining. This is a material governance event requiring Item 5.07 disclosure under SEC rules.
View raw filing on EDGAR →uniQure N.V. (QURE)
uniQure announced its plan to submit a BLA for AMT-130 in Huntington's Disease in Q3 2026, following FDA Type B meeting feedback that the 3-year Phase I/II data would be acceptable for accelerated approval. This is a material regulatory milestone for a gene therapy company, but does not fit neatly into the standard taxonomy categories (not an earnings release, executive change, M&A, impairment, or litigation). The disclosure is material to investors as it signals significant progress toward a potential regulatory approval pathway, though the event is contingent on future FDA alignment and BLA submission.
View raw filing on EDGAR →Arqit Quantum Inc. (ARQQW)
The 6-K discloses settlement of putative class action lawsuits filed against the Company and certain directors in federal and state courts. The Federal Court approved a $7 million settlement agreement on June 1, 2026, resolving the Eastern District of New York action (Case No. 1:22-cv-02604), and a separate state court action was voluntarily dismissed. The disclosure explicitly states "all of the putative class actions filed against the Company in federal and state courts in the U.S. have been resolved," indicating material litigation settlement.
View raw filing on EDGAR →Elauwit Connection, Inc. (ELWT)
The filing discloses the appointment of Nick Jones as Chief Information Officer and Chief Operating Officer effective June 15, 2026, with detailed employment terms including $300,000 annual base salary, performance bonuses, and a $50,000 sign-on RSU grant. While the section also mentions Richard Alder's departure as COO, the principal disclosed action centers on Jones's appointment to a senior dual executive role with a three-year employment agreement, making exec_appointment the most salient classification.
View raw filing on EDGAR →Verastem, Inc. (VSTM)
Verastem announced positive updated results from the RAMP 205 Phase 1b/2a clinical trial evaluating avutometinib plus defactinib in combination with chemotherapy for metastatic pancreatic cancer, with an 86% overall survival rate at 6 months, 68% progression-free survival rate, and 52% objective response rate. The company also announced initiation of dosing in the TARGET-D 201 Phase 2 registration-directed trial for VS-7375.
View raw filing on EDGAR →TENNANT CO (TNC)
The filing discloses the appointment of Richard H. Zay to Chief Operating Officer, effective July 1, 2026, a material executive promotion. While the disclosure also mentions compensatory arrangements ($400,000 in equity awards), the principal action is the appointment to a C-suite position. This is material to investors as it reflects a significant change in executive leadership and succession planning.
View raw filing on EDGAR →FRANCO NEVADA Corp (FNV)
Franco-Nevada discloses a material legal dispute arising from a Burkina Faso court decision purporting to nullify a stream agreement related to the Karma Mine. The company states it believes the judgment is invalid and is pursuing legal remedies in Ontario and elsewhere against Riverstone Karma SA and affiliates to protect its legal rights. This is a material litigation/dispute disclosure that would affect a reasonable investor's assessment of the company's cash-flow-producing assets and portfolio value.
View raw filing on EDGAR →HYUNDAI ABS FUNDING LLC
This disclosure describes the entry into multiple material definitive agreements in connection with the issuance and sale of asset-backed securities (Notes) on June 17, 2026. The core transaction involves a Receivables Purchase Agreement whereby HCA transferred retail installment sale contracts to HABS, followed by a Sale and Servicing Agreement transferring those receivables to a trust that issued the Notes. This constitutes a material securitization transaction—a form of asset disposition and financing activity that would materially affect the registrant's financial position and capital structure.
View raw filing on EDGAR →ATN International, Inc. (ATNI)
This is a classic Item 5.07 disclosure reporting the results of ATN International's Annual Meeting of Stockholders held on June 16, 2026. The filing presents voting tallies for three proposals: election of seven directors, advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material shareholder vote results disclosure.
View raw filing on EDGAR →ENTERPRISE FINANCIAL SERVICES CORP (EFSCP)
Enterprise Financial Services Corp completed a $175 million issuance of subordinated notes on June 17, 2026, pursuant to a registered offering under Form S-3, creating material direct financial obligations and expanding the company's capital structure.
View raw filing on EDGAR →Latch, Inc. (LTCHW)
The filing discloses adoption of new forms of equity award agreements (RSU, stock option, and common stock agreements) under the 2021 Incentive Award Plan and grants of time-based RSUs to three named executive officers (Dave Lillis, Jeff Mayfield, and Ryan Salmons) totaling approximately $319,636 in aggregate grant-date fair value. Item 5.02(e) explicitly identifies these as "material compensatory arrangements," and the disclosure details vesting structures, fair values, and vesting commencement dates for each executive.
View raw filing on EDGAR →Nano Dimension Ltd. (NNDM)
The filing discloses a proposed business combination between Nano Dimension Ltd. and Infinite Epigenetics, Inc., with a press release issued on June 16, 2026 providing additional information about the transaction. The disclosure references an anticipated Definitive Agreement, Form S-4 registration statement, and proxy statement/prospectus, all hallmarks of a material M&A transaction requiring shareholder approval. This is a material event that would significantly affect investor assessment of the registrant.
View raw filing on EDGAR →REGENERON PHARMACEUTICALS, INC. (REGN)
This Item 5.07 filing discloses the results of Regeneron's 2026 Annual Meeting of Shareholders held on June 12, 2026, including voting outcomes for three proposals: election of Class II directors (five nominees), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core disclosure, which is the defining characteristic of shareholder_vote_results.
View raw filing on EDGAR →MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Madrigal Pharmaceuticals held its Annual Meeting of Stockholders on June 17, 2026, with shareholders voting on five matters: re-election of three Class I directors, advisory vote on named executive officer compensation, ratification of PricewaterhouseCoopers LLP as independent auditor, approval of the 2026 Stock Plan, and approval of the 2026 Employee Stock Purchase Plan. The filing discloses complete voting tallies (For, Against, Abstentions, Broker Non-Votes) for each matter.
View raw filing on EDGAR →MADRIGAL PHARMACEUTICALS, INC. (MDGL)
The Board adopted a Nonqualified Deferred Compensation Plan for named executive officers and directors, and entered into a consulting agreement with Dr. Rebecca Taub (Class II director) providing $100,000 annually plus director compensation. These compensatory arrangements were approved by stockholders as part of the Annual Meeting voting on the 2026 Stock Plan and 2026 Employee Stock Purchase Plan.
View raw filing on EDGAR →Israel Acquisitions Corp (ISLWF)
This disclosure reports a seventh amendment to a business combination agreement (BCA) between Israel Acquisitions Corp and Gadfin Ltd., originally entered into on January 26, 2025 and amended multiple times through June 15, 2026. The amendment extends the termination date under Section 7.1(d) to June 20, 2026. This constitutes material M&A activity under Item 1.01, as it involves an ongoing material acquisition/business combination and modification of its key terms.
View raw filing on EDGAR →